Who is sponsoring NCT06038981?

NCT06038981 is sponsored by Medical University of Gdansk.

What condition does NCT06038981 study?

NCT06038981 studies Hemorrhage, Surgical, Bariatric Surgery, Tranexamic Acid.

Is NCT06038981 still recruiting?

NCT06038981 is currently completed. Last updated 22 September 2023.

Last reviewed 2023-09-22 · How we verify

NCT06038981

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of the Impact of Perioperative Administration of Tranexamic Acid on Bleeding After Sleeve Gastrectomy

Completed NA Last updated 22 September 2023

What this trial tests

NA trial testing Administration of 1g tranexamic acid intravenous bolus, after anesthesia was introduced in Hemorrhage, Surgical in 300 participants. Completed in 28 June 2023.

Timeline

4 July 2022

Primary endpoint
28 June 2023

28 June 2023

Quick facts

Lead sponsor	Medical University of Gdansk
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	300
Start date	4 July 2022
Primary completion	28 June 2023
Estimated completion	28 June 2023
Sites	1 location across Poland

Drugs / interventions tested

Administration of 1g tranexamic acid intravenous bolus, after anesthesia was introduced — full drug profile →

Conditions studied

Hemorrhage, Surgical — all drugs for Hemorrhage, Surgical →
Bariatric Surgery — all drugs for Bariatric Surgery →
Tranexamic Acid — all drugs for Tranexamic Acid →

Sponsor

Medical University of Gdansk

Who can join

18 and older, any sex, with Hemorrhage, Surgical or Bariatric Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Enhanced recovery after bariatric surgery imposes a significant reduction in length of hospital stay. However beneficial for the overall recovery it reduces the hospital observation time. after a laparoscopic surgery during which one of the longest resection line in surgery or anastomosis are created. Therefore, discovering possible safe and effective ways of pharmacologically reducing surgical blood loss and reducing the risk of postoperative bleeding would be an invaluable addition to the protocol. The systemic use of tranexamic acid (TXA) has been shown to be effective in many types of surgery, reducing the incidence of post-operative bleeding and thereby reducing the rate of reoperation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of Tranexamic Acid in Reducing Hidden Blood Loss During Laparoscopic Sleeve Gastrectomy: A Randomized Clinical Trial.
Bieniaszewski K, Proczko-Stepaniak M, Wilczyński M, Nowicki P, et al · · 2025 · cited 2× · PMID 40364042 · DOI 10.3390/jcm14093010

Verify or expand the search:

Other recruiting trials for Hemorrhage, Surgical

Currently open trials in the same condition.

NCT05077124 — Safe and Timely Antithrombotic Removal (STAR) Registry · recruiting

Other Medical University of Gdansk trials

Trials by the same sponsor.

NCT07521280 — State-Based Rehabilitation for Youth Athletes With Osgood-Schlatter or Sever-Related Apophyseal Pain · NA · not yet recruiting
NCT07446517 — Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes · NA · recruiting
NCT07449585 — Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
NCT07397208 — Assessment of the Repeatability of Sublingual Microcirculation Function Measurements in Healthy Volunteers and Criticall · not yet recruiting
NCT07345403 — GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Ana · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06038981 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Gdansk
Last refreshed: 22 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06038981.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing